A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology

[1]  John Hardy,et al.  Selective vulnerability in neurodegenerative diseases , 2018, Nature Neuroscience.

[2]  D. Kosman,et al.  The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons , 2018, Cellular and Molecular Neurobiology.

[3]  Aviv Regev,et al.  Massively-parallel single nucleus RNA-seq with DroNc-seq , 2017, Nature Methods.

[4]  D. Holtzman,et al.  Glial contributions to neurodegeneration in tauopathies , 2017, Molecular Neurodegeneration.

[5]  Geoffrey M. Barrett,et al.  Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer’s Disease , 2017, Neuron.

[6]  Dennis W Dickson,et al.  Pathology of Neurodegenerative Diseases. , 2017, Cold Spring Harbor perspectives in biology.

[7]  C. Dobson,et al.  A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease , 2016, Science Advances.

[8]  B. Hyman,et al.  3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice , 2016, PloS one.

[9]  M. Ronaghi,et al.  Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain , 2016, Science.

[10]  J. Kelly,et al.  A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases. , 2016, Current opinion in chemical biology.

[11]  Michele Vendruscolo,et al.  A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation , 2016, Proceedings of the National Academy of Sciences.

[12]  P. Hof,et al.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies , 2016, Biomolecules.

[13]  Christof Koch,et al.  Adult Mouse Cortical Cell Taxonomy by Single Cell Transcriptomics , 2016, Nature Neuroscience.

[14]  Staci A. Sorensen,et al.  Adult Mouse Cortical Cell Taxonomy Revealed by Single Cell Transcriptomics , 2016 .

[15]  B. Hyman,et al.  Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity , 2015, The EMBO journal.

[16]  C. Geula,et al.  Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease , 2015, Neurobiology of Aging.

[17]  A. Cuervo,et al.  Proteostasis and aging , 2015, Nature Network Boston.

[18]  M. Pericak-Vance,et al.  F-box/LRR-repeat protein 7 is genetically associated with Alzheimer’s disease , 2015, Annals of clinical and translational neurology.

[19]  R. Morimoto,et al.  The biology of proteostasis in aging and disease. , 2015, Annual review of biochemistry.

[20]  P. Caroni,et al.  From Intrinsic Firing Properties to Selective Neuronal Vulnerability in Neurodegenerative Diseases , 2015, Neuron.

[21]  Corey O. Brizzee,et al.  BAG3 facilitates the clearance of endogenous tau in primary neurons , 2015, Neurobiology of Aging.

[22]  Martha A. Kahlson,et al.  Glial Tau Pathology in Tauopathies: Functional Consequences , 2015, Journal of experimental neuroscience.

[23]  Marc Vidal,et al.  A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. , 2014, Cell reports.

[24]  L. Grinberg,et al.  Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.

[25]  Isidre Ferrer,et al.  Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. , 2014, Journal of neuropathology and experimental neurology.

[26]  C. Zurzolo,et al.  Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons* , 2012, The Journal of Biological Chemistry.

[27]  Naruhiko Sahara,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.

[28]  H. Kampinga,et al.  The HSPB8‐BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases , 2012, Neuropathology and applied neurobiology.

[29]  Menno P. Witter,et al.  Trans-Synaptic Spread of Tau Pathology In Vivo , 2012, PloS one.

[30]  C. Geula,et al.  Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer’s disease , 2011, Acta Neuropathologica.

[31]  Pico Caroni,et al.  Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration , 2011, Neuron.

[32]  A. Dillin,et al.  Aging as an event of proteostasis collapse. , 2011, Cold Spring Harbor perspectives in biology.

[33]  B. Vissel,et al.  Alzheimer's disease selective vulnerability and modeling in transgenic mice. , 2009, Journal of Alzheimer's disease : JAD.

[34]  W. Seeley,et al.  Selective functional, regional, and neuronal vulnerability in frontotemporal dementia , 2008, Current opinion in neurology.

[35]  Richard I. Morimoto,et al.  Adapting Proteostasis for Disease Intervention , 2008, Science.

[36]  D. Kareken,et al.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family , 2007, Brain : a journal of neurology.

[37]  M. Mattson,et al.  Ageing and neuronal vulnerability , 2006, Nature Reviews Neuroscience.

[38]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[39]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[40]  J. Morrison,et al.  Determinants of neuronal vulnerability in neurodegenerative diseases , 1998, Annals of neurology.

[41]  J. Trojanowski,et al.  Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*) , 1995, The Journal of Biological Chemistry.

[42]  D. Sparks,et al.  Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. , 1995, Archives of neurology.

[43]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[44]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.